Edible films and coatings based on agrifood residues: A new trend in the food packaging research

Food packaging trends have been changing in the last years, mainly due to consumer concerns about plastic pollution and agrifood waste. Recent advances in the development of edible films and coatings are discussed. These systems can be much more than packaging, with additional functions such as antioxidant, antimicrobial, and nutritional properties, among others. Challenges in industrial processes and/or in some films’ properties are addressed from the authors’ point of view. The use of agrifood residues in these packaging systems is included as a promising strategy that promotes sustainability and circular economy. The authors consider that more research and actions are needed to achieve the best packaging material for each food product with reduced production costs.info:eu-repo/semantics/publishedVersio

Supercritical fluid technology for agrifood materials processing

This work was financially supported by Fundação para a Ciência e Tecnologia (FCT), Portugal, through the project Strategic Project UIDB/00102/2020 and Programmatic Project UIDP/00102/2020 of the Chemical Process Engineering and Forest Products Research Centre (CIEPQPF), and UI/05704/2020 of ciTechCare. M. C. Gaspar acknowledges FCT for the financial support through the Scientific Employment Stimulus – Individual and Institutional Calls (CEECIND/00527/2017 and CEECINST/00060/2021). The authors participate in the CYTED network RESALVALOR — Valorización de Residuos de la Industria Agroalimentaria. The authors are also grateful for the work of the designer José Gomes in the preparation of Figures 1 and 2.Supercritical fluid technology has been applied in the food area for processing and preserving food products and/or monitoring the food quality, with known advantages. The main solvent used at supercritical conditions for food applications is carbon dioxide. Some examples are presented, from the traditional decaffeination of coffee up to the micronization of vanilla, passing through innovative processes such as the extrusion of protein-based snacks and drying of beetroot. The gap between research and industries is addressed, mainly due to a lack of data about food chemical changes that may occur during some processes, as well as technical data. However, this is an area in clear expansion and probably, in the future, we will have a menu composed of meals prepared by supercritical methods.info:eu-repo/semantics/publishedVersio

A review of conventional and emerging technologies for hydrogels sterilization

Funding This work was financially supported by Fundaçao ˜ para a Ciˆencia e Tecnologia (FCT), Portugal, through the project STERILAEROGEL – Green method to prepare sterilised biopolymer-based aerogel (POCI01–0145-FEDER-032625) and Strategic Projects FCT-MEC PEst-C/EQB/ UI0102/2019, UIDB/00102/2020 and Programmatic Project UIDP/ 00102/2020 of the CIEPQPF, and UI/05704/2020 of the ciTechCare. C. S. A. Bento acknowledges for PhD grant UI/BD/151008/2021 and M. C. Gaspar acknowledges FCT for the financial support under Scientific Employment Stimulus – Individual and Institutional Calls (CEECIND/ 00527/2017 and CEECINST/00060/2021).Hydrogels are extensively used in the biomedical field, as drug delivery systems, wound dressings, contact lenses or as scaffolds for tissue engineering. Due to their polymeric nature and the presence of high amounts of water in their structure, hydrogels generally present high sensitivity to terminal sterilization. The establishment of an efficient sterilization protocol that does not compromise the functional properties of the hydrogels is one of the challenges faced by researchers when developing a hydrogel for a specific application. Yet, until very recently this aspect was largely ignored in the literature. The present paper reviews the state of literature concerning hydrogels sterilization, compiling the main findings. Conventional terminal sterilization methods (heat sterilization, radiation sterilization, and gas sterilization) as well as emerging sterilization techniques (ozone, supercritical carbon dioxide) are covered. Considerations about aseptic processing are also included. Additionally, and as a framework, hydrogels’ polymeric materials, types of networks, and main biomedical applications are summarily described.info:eu-repo/semantics/publishedVersio

Biomateriais aplicados ao desenvolvimento de sistemas terapêuticos avançados

Esta obra apresenta contribuições que cobrem o estado-da-arte de vários tópicoscientíficos e técnicos e que foram desenvolvidos no âmbito das actividades científicase de formação de um projecto-em-rede CYTED, intitulado RIMADEL - Rede Ibero-Americana de Nuevos Materiales para el Diseño de Sistemas Avanzados de Liberación deFármacos en Enfermidades de Alto Impacto Socioeconómico.Este projecto pretendeu criar uma plataforma Ibero-Americana de intercâmbio deinvestigadores, de conhecimento e de recursos científicos e tecnológicos, orientadapara o desenvolvimento de novos biomateriais com aplicações em sistemas avançadosde libertação de agentes terapêuticos, e em suportes para dispositivos biomédicos eengenharia de tecidos/medicina regenerativa.Apresentam-se perspectivas abrangentes, embora muito actuais, e para que este livropossa servir também como uma obra de referência para estudantes de graduação e depós-graduação de países falantes da Língua Portuguesa ou Castelhana, em áreas comoa Engenharia (Engenharia Química, Engenharia de Materiais, Engenharia Biomédica,Engenharia Biológica), Ciências Farmacêuticas, Química, Química Medicinal, QuímicaBiológica, Bioquímica, e Biologia.</p

Transcriptome analysis reveals the high ribosomal inhibitory action of 1,4-naphthoquinone on Meloidogyne luci infective second-stage juveniles

The root-knot nematode (RKN) Meloidogyne luci presents a threat to the production of several important crops. This nematode species was added to the European Plant Protection Organization Alert list in 2017. The scarce availability of efficient nematicides to control RKN and the phasing out of nematicides from the market have intensified the search for alternatives, such as phytochemicals with bionematicidal properties. The nematicidal activity of 1,4-naphthoquinone (1,4-NTQ) against M. luci has been demonstrated; however, knowledge of the potential mode(s) of action of this compound is still scarce. In this study, the transcriptome profile of M. luci second-stage juveniles (J2), the infective stage, in response to 1,4-NTQ exposure was determined by RNA-seq to identify genes and pathways that might be involved in 1,4-NTQ’s mode(s) of action. Control treatments, consisting of nematodes exposed to Tween® 80 (1,4-NTQ solvent) and to water, were included in the analysis. A large set of differentially expressed genes (DEGs) was found among the three tested conditions, and a high number of downregulated genes were found between 1,4-NTQ treatment and water control, reflecting the inhibitory effect of this compound on M. luci, with a great impact on processes related to translation (ribosome pathway). Several other nematode gene networks and metabolic pathways affected by 1,4-NTQ were also identified, clarifying the possible mode of action of this promising bionematicide

Using High-Pressure Technology to Develop Antioxidant-Rich Extracts from Bravo de Esmolfe Apple Residues

Bravo de Esmolfe (BE) is a traditional Portuguese apple highly appreciated by consumers due to its peculiar flavor and aroma. This apple contains higher concentration of phenolic compounds than other cultivars and is thus considered a rich source of antioxidants. Its sensorial and functional properties have attracted farmers' associations to increase BE production. However, a large quantity of apples is wasted due to storage/transportation procedures that impact BE's quality attributes. In this work, we applied high-pressure extraction methodologies to generate antioxidant-rich fractions from BE residues aiming at adding high value to these agro-food by-products. We performed a first extraction step using supercritical CO2, followed by a second extraction step where different CO2 + ethanol mixtures (10-100% v/v) were tested. All experiments were carried out at 25 MPa and 50 °C. Extracts were characterized in terms of global yield, phenolic content and antioxidant activity using chemical (ORAC, HOSC, HORAC) and cell-based assays (CAA). We demonstrated that, although the pressurized 100% ethanol condition promoted the highest recovery of phenolic compounds (509 ± 8 mg GAE/100 g BE residues), the extract obtained with 40% ethanol presented the highest CAA (1.50 ± 0.24 µmol QE/g dw) and ORAC (285 ± 16 µmol TEAC/g dw), as well as HOSC and HORAC values, which correlated with its content of epicatechin and procyanidin B2. Noteworthy, this fraction inhibited free radical production in human neurospheroids derived from NT2 cells, a robust 3D cell model for neuroprotective testing

Why Are Outcomes Different for Registry Patients Enrolled Prospectively and Retrospectively? Insights from the Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF).

Background: Retrospective and prospective observational studies are designed to reflect real-world evidence on clinical practice, but can yield conflicting results. The GARFIELD-AF Registry includes both methods of enrolment and allows analysis of differences in patient characteristics and outcomes that may result. Methods and Results: Patients with atrial fibrillation (AF) and ≥1 risk factor for stroke at diagnosis of AF were recruited either retrospectively (n = 5069) or prospectively (n = 5501) from 19 countries and then followed prospectively. The retrospectively enrolled cohort comprised patients with established AF (for a least 6, and up to 24 months before enrolment), who were identified retrospectively (and baseline and partial follow-up data were collected from the emedical records) and then followed prospectively between 0-18 months (such that the total time of follow-up was 24 months; data collection Dec-2009 and Oct-2010). In the prospectively enrolled cohort, patients with newly diagnosed AF (≤6 weeks after diagnosis) were recruited between Mar-2010 and Oct-2011 and were followed for 24 months after enrolment. Differences between the cohorts were observed in clinical characteristics, including type of AF, stroke prevention strategies, and event rates. More patients in the retrospectively identified cohort received vitamin K antagonists (62.1% vs. 53.2%) and fewer received non-vitamin K oral anticoagulants (1.8% vs . 4.2%). All-cause mortality rates per 100 person-years during the prospective follow-up (starting the first study visit up to 1 year) were significantly lower in the retrospective than prospectively identified cohort (3.04 [95% CI 2.51 to 3.67] vs . 4.05 [95% CI 3.53 to 4.63]; p = 0.016). Conclusions: Interpretations of data from registries that aim to evaluate the characteristics and outcomes of patients with AF must take account of differences in registry design and the impact of recall bias and survivorship bias that is incurred with retrospective enrolment. Clinical Trial Registration: - URL: http://www.clinicaltrials.gov . Unique identifier for GARFIELD-AF (NCT01090362)

Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry.

BACKGROUND: The Global Anticoagulant Registry in the FIELD-Atrial Fibrillation (GARFIELD-AF) is an ongoing prospective noninterventional registry, which is providing important information on the baseline characteristics, treatment patterns, and 1-year outcomes in patients with newly diagnosed non-valvular atrial fibrillation (NVAF). This report describes data from Indian patients recruited in this registry. METHODS AND RESULTS: A total of 52,014 patients with newly diagnosed AF were enrolled globally; of these, 1388 patients were recruited from 26 sites within India (2012-2016). In India, the mean age was 65.8 years at diagnosis of NVAF. Hypertension was the most prevalent risk factor for AF, present in 68.5% of patients from India and in 76.3% of patients globally (P < 0.001). Diabetes and coronary artery disease (CAD) were prevalent in 36.2% and 28.1% of patients as compared with global prevalence of 22.2% and 21.6%, respectively (P < 0.001 for both). Antiplatelet therapy was the most common antithrombotic treatment in India. With increasing stroke risk, however, patients were more likely to receive oral anticoagulant therapy [mainly vitamin K antagonist (VKA)], but average international normalized ratio (INR) was lower among Indian patients [median INR value 1.6 (interquartile range {IQR}: 1.3-2.3) versus 2.3 (IQR 1.8-2.8) (P < 0.001)]. Compared with other countries, patients from India had markedly higher rates of all-cause mortality [7.68 per 100 person-years (95% confidence interval 6.32-9.35) vs 4.34 (4.16-4.53), P < 0.0001], while rates of stroke/systemic embolism and major bleeding were lower after 1 year of follow-up. CONCLUSION: Compared to previously published registries from India, the GARFIELD-AF registry describes clinical profiles and outcomes in Indian patients with AF of a different etiology. The registry data show that compared to the rest of the world, Indian AF patients are younger in age and have more diabetes and CAD. Patients with a higher stroke risk are more likely to receive anticoagulation therapy with VKA but are underdosed compared with the global average in the GARFIELD-AF. CLINICAL TRIAL REGISTRATION-URL: http://www.clinicaltrials.gov. Unique identifier: NCT01090362